[1]KOUTROUMPAKIS E,PALASKAS NL,LIN SH,et al.Modern radiotherapy and risk of cardiotoxicity[J].Chemotherapy,2020,65(3-4):65-76.
[2]KIRRESH A,WHITE L,MITCHELL A,et al.Radiation-induced coronary artery disease: a difficult clinical conundrum[J].Clin Med(Lond),2022,22(3):251-256.
[3]WEI T,CHENG Y.The cardiac toxicity of radiotherapy-a review of characteristics,mechanisms,diagnosis,and prevention[J].Int J Radiat Biol,2021,97(10):1333-1340.
[4]RAGHUNATHAN D,KHILJI MI,HASSAN SA,et al.Radiation-induced cardiovascular disease[J].Curr Atheroscler Rep,2017,19(5):22.
[5]VALLERIO P,MALOBERTI A,PALAZZINI M,et al.Thoracic radiotherapy as a risk factor for heart ischemia in subjects treated with chest irradiation and chemotherapy and without classic cardiovascular risk factors[J].Radiother Oncol,2020,152:146-150.
[6]LPEZ-FERNNDEZ TERESA,LYON AR,JOERG H.2022 Esc guidelines on cardio-oncology:How can we improve the cardiovascular health of patients with cancer and cancer survivors[J].European Heart Journal-Cardiovascular Pharmacotherapy,2022,9(1):4-5.
[7]CARO-CODON J,JIMENEZ-VALERO S,GALEOTE G,et al.Radiation-induced coronary artery disease:Useful insights from OCT[J].Int J Cardiol,2016,202:535-536.
[8]IMBALZANO E,TRAPANI G,CREAZZO M,et al.Coronary artery disease in radiotherapy[J].Int J Cardiol,2013,168(4):e125-e126.
[9]CUOMO JR,JAVAHERI SP,SHARMA GK,et al.How to prevent and manage radiation-induced coronary arterydisease[J].Heart,2018,104(20):1647-1653.
[10]VOJTISEK R.Cardiac toxicity of lung cancer radiotherapy[J].Rep Pract Oncol Radiother,2020,25(1):13-19.
[11]ZHUANG XF,YANG YM,SUN XL,et al.Late onset radiation-induced constrictive pericarditis and cardiomyopathy after radiotherapy:A case report[J].Medicine(Baltimore),2017,96(5):e5932.
[12]QUINTERO-MARTINEZ JA,CORDOVA-MADERA SN,VILLARRAGA HR.Radiation-Induced heart disease[J].Journal of Clinical Medicine,2021,11(1):20-21.
[13]MARINKO T.Pericardial disease after breast cancer radiotherapy[J].Radiol Oncol,2018,53(1):1-5.
[14]MA CX,ZHAO XK,LI YD.New therapeutic insights into radiation-induced myocardial fibrosis[J].Ther Adv Chronic Dis,2019,10:1753160159.
[15]PANPAN T,YUCHEN D,XIANYONG S,et al.Cardiac remodelling following cancer therapy:A review[J]Cardiovasc Toxicol,2022,22(9):771-786.
[16]CUOMO JR,SHARMA GK,CONGER PD,et al.Novel concepts in radiation-induced cardiovascular disease[J].World J Cardiol,2016,8(9):504-519.
[17]DONNELLAN E,PHELAN D,MCCARTHY CP,et al.Radiation-induced heart disease:A practical guide to diagnosis and management[J].Cleve Clin J Med,2016,83(12):914-922.
[18]MADANR,BENSON R,SHARMA DN,et al.Radiation induced heart disease:Pathogenesis,management and review literature[J].J Egypt Natl Canc Inst,2015,27(4):187-193.
[19]DESAI MY,JELLIS CL,KOTECHA R,et al.Radiation-associated cardiac disease:A practical approach to diagnosis and management[J].JACC Cardiovasc Imaging,2018,11(8):1132-1149.
[20]ADAMS MJ,LIPSITZ SR,COLAN SD,et al.Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy[J].J Clin Oncol,2004,22(15):3139-3148.
[21]VAN NIMWEGEN FA,SCHAAPVELD M,CUTTER DJ,et al.Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma[J].J Clin Oncol,2016,34(3):235-243.
[22]KIM L,LOCCOH EC,SANCHEZ R,et al.Contemporary understandings of cardiovascular disease after cancer radiotherapy:A focus on ischemic heart disease[J].Curr Cardiol Rep,2020,22(11):151.
[23]LIN SH,HOBBS BP,VERMA V,et al.Randomized phase Ⅱb trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer[J].J Clin Oncol,2020,38(14):1569-1579.
[24]WENNSTIG AK,GARMO H,WADSTEN L,et al.Risk of coronary stenosis after adjuvant radiotherapy for breast cancer[J].Strahlenther Onkol,2022,198(7):630-638.
[25]CHEN CH,HSIEH CC,CHANG CS,et al.A Retrospective analysis of dose distribution and toxicity in patients with left breast cancer treated with adjuvant intensity-modulated radiotherapy: Comparison with three-dimensional conformal radiotherapy[J].Cancer Manag Res,2020,12:9173-9182.
[26]AMIN NP,DESAI N,KIM SM,et al.Cardiac monitoring for thoracic radiation therapy:Survey of practice patterns in the united states[J].Am J Clin Oncol,2020,43(4):249-256.
[27]BOERMA M,SRIDHARAN V,MAO XW,et al.Effects of ionizing radiation on the heart[J].Mutat Res,2016,770(Pt B):319-327.
[28]WANG B,WANG H,ZHANG M,et al.Radiation-induced myocardial fibrosis:Mechanisms underlying its pathogenesis and therapeutic strategies[J].J Cell Mol Med,2020,24(14):7717-7729.
[29]STEINER I.Pathology of radiation induced heart disease[J].Rep Pract Oncol Radiother,2020,25(2):178-181.
[30]TAUNK NK,HAFFTY BG,KOSTIS JB,et al.Radiation-induced heart disease:Pathologic abnormalities and putative mechanisms[J].Front Oncol,2015,5:39.
[31]WANG H,WEI J,ZHENG Q,et al.Radiation-induced heart disease:A review of classification,mechanism and prevention[J].Int J Biol Sci,2019,15(10):2128-2138.
[32]KIYOHARA H,ISHIZAKI Y,SUZUKI Y,et al.Radiation-induced ICAM-1 expression via TGF-beta1 pathway on human umbilical vein endothelial cells,comparison between X-ray and carbon-ion beam irradiation[J].J Radiat Res,2011,52(3):287-292.
[33]LEASK A.Potential therapeutic targets for cardiac fibrosis:TGF beta,angiotensin,endothelin,CCN2,and PDGF,partners in fibroblast activation[J].Circ Res,2010,106(11):1675-1680.
[34]MUN GI,KIM S,CHOI E,et al.Pharmacology of natural radioprotectors[J].Arch Pharm Res,2018,41(11):1033-1050.
[35]STARK J.Oxidativestress andatherosclerosis[J].Orv Hetil,2015,156(28):1115-1119.
[36]WANG KX,YE C,YANG X,et al.New insights into the understanding of mechanisms of radiation-induced heart disease[J].Curr Treat Options Oncol,2023,24(1):12-29.
[37]RAGHUNATHAN D,KHILJI MI,HASSAN SA,et al.Radiation-Induced cardiovascular disease[J].Curr Atheroscler Rep,2017,19(5):22.
[38]SLEZAK J,KURA B,BABAL P,et al.Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury[J].Can J Physiol Pharmacol,2017,95(10):1190-1203.
[39]SHIVAPPA P,BERNHARDT GV.Natural radioprotectors on current and future perspectives:A mini-review[J].J Pharm Bioallied Sci,2022,14(2):57-71.
[40]MUSA AE,SHABEEB D.Radiation-Induced heart diseases:Protective effects of natural products[J].Medicina(Kaunas,Lithuania),2019,55(5):126.
[41]GE L,LI C,WANG Z,et al.Suppression of oxidative stress and apoptosis in electrically stimulated neonatal rat cardiomyocytes by resveratrol and underlying mechanisms[J].J Cardiovasc Pharmacol,2017,70(6):396-404.
[42]YANG R,TAN C,NAJAFI M.Cardiac inflammation and fibrosis following chemo/radiation therapy:Mechanisms and therapeutic agents[J].Inflammopharmacology,2022,30(1):73-89.
[43]DREYFUSS AD,VELALOPOULOU A,AVGOUSTI H,et al.Preclinical models of radiation-induced cardiac toxicity:Potential mechanisms and biomarkers[J].Front Oncol,2022,12:920867.
[44]CCILE MORO,JOUAN MG,RAKOTOVAO A,et al.Delayed expression of cytokines after reperfused myocardial infarction:Possible trigger for cardiac dysfunction and ventricular remodeling[J].Heart & Circulatory Physiology,2007,62(5):H3014-H3019.
[45]BOCK FJ,TAIT S.Mitochondria as multifaceted regulators of cell death[J].Nat Rev Mol Cell Biol,2020,21(2):85-100.
[46]WANG H,WEI J,ZHENG Q,et al.Radiation-induced heart disease:A review of classification,mechanism and prevention[J].Int J Biol Sci,2019,15(10):2128-2138.
[47]KURA B,BABAL P,SLEZAK J.Implication of microRNAs in the development and potential treatment of radiation-induced heart disease[J].Can J Physiol Pharmacol,2017,95(10):1236-1244.
[48]TOMASZEWSKI JM,CROOK S,WAN K,et al.A case study evaluating deep inspiration breath-hold and intensity-modulated radiotherapy to minimise long-term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma[J].Journal of Medical Radiation Ences,2017,64(1):69-75.
[49]KHAN SU,SAEED S,SHEIKH AN,et al.Crafting a blueprint for microRNA in cardiovascular diseases(CVDs)[J].Curr Probl Cardiol,2023,48(12):102010.
[50]WANG Y,SCHEIBER MN,NEUMANN C,et al.MicroRNA regulation of ionizing radiation-induced premature senescence[J].Int J Radiat Oncol Biol Phys,2011,81(3):839-848.
[51]ZHU H,FAN GC.Role of microRNAs in the reperfused myocardium towards post-infarct remodelling[J].Cardiovasc Res,2012,94(2):284-292.
[52]VICZENCZOVA C,KURA B,EGAN BT,et al.Irradiation-induced cardiac connexin-43 and miR-21 responses are hampered by treatment with atorvastatin and aspirin[J].International Journal of Molecular Sciences,2018,19(4):1128-1138.
[53]KWON OS,KIM KT,LEE E,et al.Induction of miR-21 by stereotactic body radiotherapy contributes to the pulmonary fibrotic response[J].PLoS One,2016,11(5):e154942.
[54]CHEN Y,CUI J,GONG Y,et al.MicroRNA:A novel implication for damage and protection against ionizing radiation[J].Environ Sci Pollut Res Int,2021,28(13):15584-15596.